Clinical Trials Directory

Trials / Completed

CompletedNCT00733200

Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
26 Years – 72 Years
Healthy volunteers
Not accepted

Summary

The investigators conducted a prospective study to determine the safety and efficacy of minor and major hepatectomy selected by predetermined criteria in 138 patients with hilar cholangiocarcinoma. In selected patients, minor liver resection was a good treatment.

Detailed description

Objective: To determine the safety and efficacy of minor and major hepatectomy selected by predetermined criteria in patients with hilar cholangiocarcinoma (HC). Summary Background Data: For HC treated with hepatectomy, the extent of liver resection remains controversial despite extensive studies. Methods: From January 2000 to December 2007, we prospectively studied patients who received surgical treatment for HC. Of the 187 patients who were surgically treated, 138 (73.8%) underwent resection with a curative intent. Minor hepatectomy was carried out in 93 patients who had Bismuth-Corlette types I, II and III HC without hepatic artery/portal vein invasion; and major hepatectomy in 45 patients who had type III HC with hepatic artery/portal vein invasion, or type IV HC.

Conditions

Interventions

TypeNameDescription
PROCEDUREMinor or Major Liver Resection

Timeline

First posted
2008-08-12
Last updated
2009-12-11

Source: ClinicalTrials.gov record NCT00733200. Inclusion in this directory is not an endorsement.